Pharmacogenomics draft guidance
Executive Summary
FDA is understood to be on track to release its pharmacogenomics draft guidance in August. The draft guidance is understood to state that FDA will not require sponsors to collect pharmacogenomics data for product applications (1"The Pink Sheet" April 14, 2003, p. 12). The Drug Information Association is planning a meeting on pharmacogenomics for November...